Geovax Labs, Inc. 1900 Lake Park Drive Suite 380 Smyrna,
GA 30080 United States - Map
Phone: 678-384-7220
Fax: 678-384-7281
Web Site: http://www.geovax.com
| GeoVax Labs, Inc., a clinical stage biotechnology company, develops human vaccines for diseases caused by human immunodeficiency virus (HIV) and other infectious agents. Its DNA (deoxyribonucleic acid) and MVA (Modified Vaccinia Ankara) vaccines are in Phase II human clinical trial by the HIV Vaccine Trials Network. The company was founded in 2001 and is based in Smyrna, Georgia. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Donald G. Hildebrand , 68 Founder, Chairman and Consultant |
$
112.00K | N/A | Dr. Robert T. McNally Ph.D., 61 Chief Exec. Offier, Pres and Member of Board of Directors |
$
179.00K | N/A | Ms. Harriet Robinson Ph.D., 71 Co-Founder, Sr. VP of R&D |
$
234.00K | N/A | Mr. Mark W. Reynolds CPA, 47 Chief Financial Officer, Principal Accounting Officer and Sec. |
$
120.00K | N/A | Dr. Mark Keister , VP of Tech Transfer and QA |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|